Experienced in Kimura Disease

Dr. Thomas L. Jang

Urology | Surgical Oncology
Altru Health System
1200 S Columbia Rd, 
Grand Forks, ND 
 (975.3 mi)
Accepting New Patients
Experienced in Kimura Disease
Altru Health System
1200 S Columbia Rd, 
Grand Forks, ND 
 (975.3 mi)
OverviewInsuranceLocationsClinical Research

Overview

Thomas Jang is an Urologist and a Surgical Oncologist in Grand Forks, North Dakota. Dr. Jang and is rated as an Experienced provider by MediFind in the treatment of Kimura Disease. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Jang is currently accepting new patients.

His clinical research consists of co-authoring 81 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Surgical Oncology
Licenses
Urology in NY
Hospital Affiliations
Centrastate Medical Center
Southern Ocean Medical Center
Altru Hospital
Hunterdon Medical Center
Robert Wood Johnson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Medica

Locations

ALTRU HEALTH SYSTEM
1200 S Columbia Rd, Grand Forks, ND 58201
Other Locations
ALTRU HEALTH SYSTEM
4440 S Washington St, Grand Forks, ND 58201
ALTRU HEALTH SYSTEM
1380 S Columbia Rd, Grand Forks, ND 58201
RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM
195 Little Albany St, New Brunswick, NJ 08901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Procedure, Other
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2024
Intervention Type: Procedure, Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

81 Total Publications

The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement.
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement.
Journal: Current opinion in urology
Published: October 01, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile